Altogether, these observations indicate that SGLT2 appears to be an interesting target to protect the vascular system in diabetes, and possibly also to retard ageing‐ and cardiovascular risk factor‐related endothelial dysfunction. This evidence concerns the gene SLC5A2 and endothelial dysfunction.